12-20855146-T-TAATTG
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_019844.4(SLCO1B3):c.205_209dup(p.Asp70GlufsTer13) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,609,310 control chromosomes in the GnomAD database, including 34 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0038 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 27 hom. )
Consequence
SLCO1B3
NM_019844.4 frameshift
NM_019844.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.751
Genes affected
SLCO1B3 (HGNC:10961): (solute carrier organic anion transporter family member 1B3) This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of endogenous and xenobiotic compounds and plays a critical role in bile acid and bilirubin transport. Mutations in this gene are a cause of Rotor type hyperbilirubinemia. Alternative splicing of this gene and the use of alternative promoters results in transcript variants encoding different isoforms that differ in their tissue specificity. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS2
High Homozygotes in GnomAd4 at 7 Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLCO1B3 | NM_019844.4 | c.205_209dup | p.Asp70GlufsTer13 | frameshift_variant | 4/16 | ENST00000381545.8 | |
SLCO1B3-SLCO1B7 | NM_001371097.1 | c.205_209dup | p.Asp70GlufsTer13 | frameshift_variant | 2/16 | ||
SLCO1B3 | NM_001349920.2 | c.121_125dup | p.Asp42GlufsTer13 | frameshift_variant | 2/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLCO1B3 | ENST00000381545.8 | c.205_209dup | p.Asp70GlufsTer13 | frameshift_variant | 4/16 | 2 | NM_019844.4 | P1 | |
SLCO1B3 | ENST00000261196.6 | c.205_209dup | p.Asp70GlufsTer13 | frameshift_variant | 2/14 | 1 | P1 | ||
SLCO1B3 | ENST00000540853.5 | c.205_209dup | p.Asp70GlufsTer13 | frameshift_variant | 3/8 | 1 | |||
SLCO1B3 | ENST00000545880.1 | n.57_61dup | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00380 AC: 579AN: 152236Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
579
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00416 AC: 1024AN: 245910Hom.: 9 AF XY: 0.00409 AC XY: 544AN XY: 132962
GnomAD3 exomes
AF:
AC:
1024
AN:
245910
Hom.:
AF XY:
AC XY:
544
AN XY:
132962
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00348 AC: 5072AN: 1456956Hom.: 27 Cov.: 30 AF XY: 0.00347 AC XY: 2518AN XY: 724844
GnomAD4 exome
AF:
AC:
5072
AN:
1456956
Hom.:
Cov.:
30
AF XY:
AC XY:
2518
AN XY:
724844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00380 AC: 579AN: 152354Hom.: 7 Cov.: 32 AF XY: 0.00447 AC XY: 333AN XY: 74496
GnomAD4 genome
AF:
AC:
579
AN:
152354
Hom.:
Cov.:
32
AF XY:
AC XY:
333
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Rotor syndrome Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 15, 2022 | The SLCO1B3 c.205_209dup; p.Asp70GlufsTer13 variant (rs558592800) is reported in the literature as one among several variants in one family with autism spectrum disorder, but with no details on hemolytic anemia or related phenotype (Yuen 2015). This variant is also reported in ClinVar (Variation ID: 712105). This variant is found in the general population with an overall allele frequency of 0.4% (1243/277294 alleles, including 13 homozygotes) in the Genome Aggregation Database. This variant causes a frameshift by inserting 5 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 03, 2018 | - - |
SLCO1B3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 01, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at